By Dr. Liji Thomas, MD From: news-medical.net Background Mammographic density (MD) reflects the proportion or amount of fibroglandular tissue in the breast, depending on the measurement method. Fibroglandular tissue contains epithelial and stromal components that can become malignant. Higher mammographic density is associated with a higher risk of breast cancer. MD is assessed in various ways: as percentage density, density …
Signs Breast Cancer Has Spread to the Bones (Metastasis)
Like any cancer, breast cancer can spread to other parts of the body. Breast cancer that has invaded bone can have a significant effect on quality of life, but there are treatments to help manage symptoms and slow disease progression. Read on to learn more about metastatic breast cancer in bones, including symptoms and what you can expect from treatment. …
FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer
From: .google.com The FDA has approved imlunestrant (Inluriyo) plus abemaciclib (Verzenio) for the treatment of adult patients with estrogen receptor (ER)–positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, who experience disease progression after 1 or more lines of endocrine therapy.1 This regulatory decision was backed by data from the phase 3 EMBER-3 trial (NCT04975308). …
Living with Breast Cancer: Understanding the Physical and Mental Changes
From: healthline.com During breast cancer treatment, you may experience several physical and mental changes. How does the body change during overall treatment? Menstrual changes Breast cancer treatments can disrupt hormone production and interrupt your menstrual cycle. This means you may experience: night sweats hot flashes joint pain weight gain a loss of sex drive vaginal dryness fertility challenges Sometimes, regular …
Estrogen Receptor (ER) Positive Breast Cancer
From: healthline.com When breast cancer cells test positive for estrogen receptors, it’s called estrogen receptor-positive (ER-positive) breast cancer. It means that estrogen is fueling the growth of the cancer. It’s one of several important characteristics of breast cancer that help determine the best treatment options. In this article, we’ll examine the role of hormone receptors in breast cancer and how …
TTC Safety in HER2+ Metastatic Breast Cancer: Key Findings
By: Jessica Nye, Ph From: oncologynurseadvisor.com n a safety review of the HER2CLIMB trial, grade 3 or higher AEs occurred in 55.2% of patients receiving TTC compared with 48.7% receiving placebo, with diarrhea being the primary AE requiring dose modifications. A detailed safety assessment of the combination of tucatinib with trastuzumab and capecitabine (TTC) was published in The Oncologist. The …
New analysis points to low overdiagnosis in breast cancer screening
Source: University of Southern Denmark Faculty of Health Sciences From: eurekalert.org/new When women take part in breast cancer screening, they are informed that screening may detect cancers that would never have caused symptoms or problems during their lifetime. This is known as overdiagnosis. The extent of overdiagnosis has been one of the most debated issues in breast cancer screening for …
Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology Target?
From: oncodaily.com Brain metastases remain one of the most difficult complications of metastatic breast cancer. Approximately 30% of patients with metastatic disease will eventually develop central nervous system involvement, and despite major improvements in systemic therapy, CNS progression continues to influence survival, quality of life, and treatment sequencing. A 2026 study published in ESMO Open now adds another dimension to …
Four-drug regimen may offer chemotherapy-free alternative in metastatic breast cancer
By Mark Leiser From: healio.com Key takeaways: First-line anastrozole, trastuzumab, pertuzumab and palbociclib conferred a 97% clinical benefit rate in the single-arm ASPIRE trial. Larger studies are needed to compare the regimen with standard therapy. A chemotherapy-free regimen offered durable disease control for certain patients with advanced breast cancer, according to results of the phase 1/phase 2 ASPIRE trial. The …
How Urgent Is Surgery for Breast Cancer?
From: healthline.com Surgery is a very common treatment for breast cancer. According to the American Cancer Society (ACS)Trusted Source, most people with nonmetastatic breast cancer will have some type of surgery, often in addition to other treatments. If you or a loved one has recently received a diagnosis of breast cancer, you may be wondering exactly how urgent surgery is. …
